Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Non-Consolidated Financial Results
for the Nine Months Ended December 31, 2020
(Based on Japanese GAAP)
Company name: RIBOMIC Inc.
Stock exchange listing: Tokyo
Stock code: Representative:
Yoshikazu Nakamura | |
Takaaki Imano | |
Scheduled date to file Quarterly Securities Report: | February 12, 2021 |
Scheduled date to commence dividend payments: | - |
Preparation of supplementary material on quarterly financial results: | No |
Holding of quarterly financial results meeting: | No |
Inquiries:
4591 URLhttps://www.ribomic.com/ President and CEO
Executive Senior Director of Business Administration
TEL
03(3440)3745
February 12, 2021
(Amounts less than one million yen are rounded down)
1. Non-consolidated financial results for the nine months ended December 31, 2020 (from April 1, 2020 to December 31, 2020)
(1) Non-consolidated operating results (cumulative)
Percentages indicate year-on-year changes
Operating revenues | Operating income | Ordinary income | Profit | |||||
Nine months ended December 31, 2020 Nine months ended December 31, 2019 | Millions of yen 5 5 | % 2.2 - | Millions of yen (838) (654) | % - - | Millions of yen (851) (651) | % - - | Millions of yen (853) (652) | % - - |
Earnings per share | Diluted earnings per share | |
Nine months ended December 31, 2020 Nine months ended December 31, 2019 | Yen (34.14) (41.70) | Yen - - |
Note：Diluted earnings per share is not shown because a loss per share was incurred even though dilutive common shares exist.
(2) Non-consolidated financial position
Total assets | Net assets | Equity ratio | |
As of December 31, 2020 As of March 31, 2020 | Millions of yen 6,663 2,269 | Millions of yen 6,336 2,180 | % 95.1 95.3 |
Reference: Equity | As of December 31, 2020 | ¥6,335 million |
As of March 31, 2020 | ¥2,164 million | |
2. Cash dividends |
Annual dividends per share | |||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | |
Year ended March 31, 2020 Year ending March 31, 2021 | Yen - - | Yen 0.00 0.00 | Yen - - | Yen 0.00 | Yen 0.00 |
Year ending March 31, 2021 (Forecast) | 0.00 | 0.00 |
Note: Revisions to the cash dividends forecast most recently announced: No
3. Forecast of non-consolidated financial results for the year ending March 31, 2021 (from April 1, 2020 to March 31, 2021)
Percentages indicate year-on-year changes
Operating revenues | Operating income | Ordinary income | Profit | Earnings per share | |||||
Full year | Millions of yen 91 | % (24.3) | Millions of yen (1,274) | % - | Millions of yen (1,216) | % - | Millions of yen (1,218) | % - | Yen (47.39) |
Notes: 1. Revisions to the non-consolidated financial results forecast most recently announced: Yes
2. The company only provides full-year forecasts as it manages its performance on an annual basis.
4. Notes
(1) Application of special accounting methods for preparing quarterly non-consolidated financial statements: No
(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
Changes in accounting policies due to revisions to accounting standards and other regulations: Changes in accounting policies due to other reasons:
Changes in accounting estimates:
Restatement of prior period financial statements:
No No No No
(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of December 31, 2020
27,908,784 shares
As of March 31, 2020
17,555,784 shares
Number of treasury shares at the end of the period
As of December 31, 2020
- shares
As of March 31, 2020
- shares
Average number of shares during the period (cumulative from the beginning of the fiscal year)
Nine months ended December 31, 2020 | 24,994,235 shares | Nine months ended December 31, 2019 | 15,639,717 shares |
* This quarterly financial results summary is not subject to quarterly review procedures by certified public accountants or auditing firms.
* Explanation on appropriate use of business forecasts, and other special notes
Business forecasts and other forward-looking statements contained in this report are based on information currently available to the company and on certain assumptions that the company considers to be reasonable, and do not constitute guarantees of future performance. Actual results may differ significantly from these forecasts due to various factors.
Quarterly non-consolidated financial statements Non-consolidated balance sheets
(Thousands of yen) | ||
As of March 31, 2020 | As of December 31, 2020 | |
Assets | ||
Current assets | ||
Cash and deposits | 1,601,728 | 3,808,807 |
Accounts receivable - trade | 108,830 | - |
Securities | 399,994 | 2,600,000 |
Supplies | 6,364 | 3,184 |
Advance payments - trade | 2,390 | 113,524 |
Prepaid expenses | 18,764 | 34,181 |
Consumption taxes receivable | 34,028 | 27,555 |
Other | 3,493 | 3,420 |
Total current assets | 2,175,594 | 6,590,674 |
Non-current assets | ||
Property, plant and equipment | 55,812 | 37,321 |
Intangible assets | 1,626 | 224 |
Investments and other assets | 36,704 | 35,724 |
Total non-current assets | 94,143 | 73,269 |
Total assets | 2,269,737 | 6,663,944 |
Liabilities | ||
Current liabilities | ||
Accounts payable - other | 24,230 | 127,386 |
Accrued expenses | 10,202 | 13,211 |
Income taxes payable | 28,038 | 22,097 |
Advances received | 6,875 | 91,687 |
Other | 19,442 | 73,004 |
Total current liabilities | 88,788 | 327,386 |
Total liabilities | 88,788 | 327,386 |
Net assets | ||
Shareholders' equity | ||
Capital stock | 4,029,956 | 6,542,185 |
Capital surplus | 4,002,956 | 6,515,185 |
Retained earnings | (5,868,737) | (6,722,074) |
Total shareholders' equity | 2,164,174 | 6,335,296 |
Share acquisition rights | 16,773 | 1,261 |
Total net assets | 2,180,948 | 6,336,557 |
Total liabilities and net assets | 2,269,737 | 6,663,944 |
Non-consolidated statements of income (cumulative)
(Thousands of yen) | ||
Nine months ended December 31, 2019 | Nine months ended December 31, 2020 | |
Operating revenues | 5,758 | 5,886 |
Operating expenses | ||
Research and development expenses | 396,807 | 562,459 |
Selling, general and administrative expenses | 263,897 | 281,638 |
Total operating expenses | 660,705 | 844,097 |
Operating loss | (654,947) | (838,211) |
Non-operating income | ||
Subsidy income | 6,018 | 11,818 |
Other | 1,512 | 877 |
Total non-operating income | 7,530 | 12,695 |
Non-operating expenses | ||
Share issuance cost | 3,878 | 20,414 |
Foreign exchange losses | - | 5,512 |
Total non-operating expenses | 3,878 | 25,927 |
Ordinary loss | (651,294) | (851,442) |
Extraordinary loss | ||
Loss on retirement of non-current assets | - | 985 |
Total extraordinary loss | - | 985 |
Loss before income taxes | (651,294) | (852,428) |
Income taxes | 907 | 907 |
Loss | (652,201) | (853,336) |